IN-DATE
10-102: Inari FlowTriever 12F Embolectomy Catheter 11-14mm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $1,500.00 $525.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 39 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 16 hours 51 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Related Items
QUICK VIEW
| 10-103 - Size: 12.0F $525.00 per box of 1 Inari FlowTriever 12F Embolectomy Catheter 15-18mm Expired Units in stock: 43 box of 1 | Order Qty |
|
QUICK VIEW
| 10-104 - Size: 12.0F $525.00 per box of 1 Inari FlowTriever 12F Embolectomy Catheter 19-25mm Expired Units in stock: 42 box of 1 | Order Qty |
|
QUICK VIEW
| 10-101 - Size: 12.0F $525.00 per box of 1 Inari FlowTriever 12F Embolectomy Catheter 6-10mm Expired Units in stock: 41 box of 1 | Order Qty |
QUICK VIEW
| 11-102 - Size: 12.0F $1,249.50 per box of 1 Inari FlowTriever2 12F Embolectomy Catheter 6-16mm Expired Units in stock: 21 box of 1 | Order Qty |
Additional Details
Inari FlowTriever Embolectomy Catheter
10-102
- Size: 12F (4mm)
- Recommended Guidewire Size: 0.035" (0.9mm)
- Usable Length: 115cm
Manufacturer
Inari Medical specializes in innovative, catheter-based solutions for venous thromboembolism (VTE). Their flagship products include the ClotTriever system for mechanical thrombectomy in deep vein thrombosis (DVT) and the FlowTriever system, the first FDA-cleared device for pulmonary embolism (PE) treatment without the need for thrombolytics. These systems are designed to remove large clots in a single session, reducing the need for ICU stays, thrombolytic drugs, and prolonged hospitalizations. With a focus on transforming the treatment paradigm for venous disease, Inari is redefining outcomes for patients suffering from life-threatening clot-related conditions.
